[Cardiac biomarkers for diagnosis of myocardial infarction].
Diagnosis of postoperative myocardial infarction is often difficult, based on tools with a low sensitivity (clinical symptoms, EKG), or with a low specifity (old biomarkers, echocardiographic abnormalities) or inadequate for clinical practice (scintigraphy). Since 1995, clinicians may use more cardiospecific markers (troponin) allowing to modify strategy for postoperative myocardial infarction diagnosis. The aim of this review is to resume such an attitude.
Godet
G
G
Département d'anesthésie et réanimation 2, hôpital Pontchaillou, 2, rue Henri-Le-Guilloux, 35033 Rennes cedex, France. gilles.godet@chu-rennes.fr
Bernard
M
M
Ben Ayed
S
S
D000789:Angina, Unstable / Q000097:blood / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood; D006348:Cardiac Surgical Procedures; D052279:Creatine Kinase, MB Form / Q000097:blood*; D003937:Diagnosis, Differential; D006801:Humans; D007124:Immunoenzyme Techniques; D018482:Muscle, Skeletal / Q000737:chemistry; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009206:Myocardium / Q000737:chemistry; D009211:Myoglobin / Q000097:blood*; D009928:Organ Specificity; D019990:Perioperative Care; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis*; D015203:Reproducibility of Results; D012151:Resuscitation; D012680:Sensitivity and Specificity; D013514:Surgical Procedures, Operative; D014336:Troponin / Q000097:blood* / Q000235:genetics; D014947:Wounds and Injuries / Q000097:blood
D015415:Biomarkers; D009211:Myoglobin; D014336:Troponin; D052279:Creatine Kinase, MB Form